Follow
Sandra Ciesek
Sandra Ciesek
University Hospital Frakfurt
Verified email at kgu.de
Title
Cited by
Cited by
Year
Papain-like protease regulates SARS-CoV-2 viral spread and innate immunity
D Shin, R Mukherjee, D Grewe, D Bojkova, K Baek, A Bhattacharya, ...
Nature 587 (7835), 657-662, 2020
9552020
Proteomics of SARS-CoV-2-infected host cells reveals therapy targets
D Bojkova, K Klann, B Koch, M Widera, D Krause, S Ciesek, J Cinatl, ...
Nature 583 (7816), 469-472, 2020
9182020
Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China
S Hoehl, H Rabenau, A Berger, M Kortenbusch, J Cinatl, D Bojkova, ...
New England Journal of Medicine 382 (13), 1278-1280, 2020
7702020
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7412021
A lymphotoxin-driven pathway to hepatocellular carcinoma
J Haybaeck, N Zeller, MJ Wolf, A Weber, U Wagner, MO Kurrer, J Bremer, ...
Cancer cell 16 (4), 295-308, 2009
4432009
Reduced neutralization of SARS-CoV-2 Omicron variant by vaccine sera and monoclonal antibodies
A Wilhelm, M Widera, K Grikscheit, T Toptan, B Schenk, C Pallas, ...
MedRxiv, 2021.12. 07.21267432, 2021
3652021
Detection of SARS-CoV-2 in raw and treated wastewater in Germany–suitability for COVID-19 surveillance and potential transmission risks
S Westhaus, FA Weber, S Schiwy, V Linnemann, M Brinkmann, M Widera, ...
Science of The Total Environment 751, 141750, 2021
3642021
The green tea polyphenol, epigallocatechin‐3‐gallate, inhibits hepatitis C virus entry
S Ciesek, T von Hahn, CC Colpitts, LM Schang, M Friesland, J Steinmann, ...
Hepatology 54 (6), 1947-1955, 2011
3492011
Next-generation sequencing of T and B cell receptor repertoires from COVID-19 patients showed signatures associated with severity of disease
C Schultheiß, L Paschold, D Simnica, M Mohme, E Willscher, ...
Immunity 53 (2), 442-455. e4, 2020
3092020
Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes
D Bankwitz, E Steinmann, J Bitzegeio, S Ciesek, M Friesland, E Herrmann, ...
Journal of virology 84 (11), 5751-5763, 2010
2762010
SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes
D Bojkova, JUG Wagner, M Shumliakivska, GS Aslan, U Saleem, ...
Cardiovascular research 116 (14), 2207-2215, 2020
2422020
Interferon-α–induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection
KA Stegmann, NK Björkström, H Veber, S Ciesek, P Riese, J Wiegand, ...
Gastroenterology 138 (5), 1885-1897. e10, 2010
2272010
Growth factor receptor signaling inhibition prevents SARS-CoV-2 replication
K Klann, D Bojkova, G Tascher, S Ciesek, C Münch, J Cinatl
Molecular cell 80 (1), 164-174. e4, 2020
2142020
The clinically approved drugs amiodarone, dronedarone and verapamil inhibit filovirus cell entry
G Gehring, K Rohrmann, N Atenchong, E Mittler, S Becker, F Dahlmann, ...
Journal of Antimicrobial Chemotherapy 69 (8), 2123-2131, 2014
2122014
Brief clinical evaluation of six high-throughput SARS-CoV-2 IgG antibody assays
N Kohmer, S Westhaus, C Rühl, S Ciesek, HF Rabenau
Journal of Clinical Virology 129, 104480, 2020
2032020
Clinical performance of different SARS‐CoV‐2 IgG antibody tests
N Kohmer, S Westhaus, C Rühl, S Ciesek, HF Rabenau
Journal of Medical Virology 92 (10), 2243-2247, 2020
1762020
Omicron BA. 1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
J Quandt, A Muik, N Salisch, BG Lui, S Lutz, K Krüger, AK Wallisch, ...
Science immunology 7 (75), eabq2427, 2022
1642022
The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro
N Kohmer, T Toptan, C Pallas, O Karaca, A Pfeiffer, S Westhaus, ...
Journal of clinical medicine 10 (2), 328, 2021
1602021
Lack of antiviral activity of darunavir against SARS-CoV-2
S De Meyer, D Bojkova, J Cinatl, E Van Damme, C Buyck, M Van Loock, ...
International Journal of Infectious Diseases 97, 7-10, 2020
1512020
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A
S Ciesek, E Steinmann, H Wedemeyer, MP Manns, J Neyts, N Tautz, ...
Hepatology 50 (5), 1638-1645, 2009
1512009
The system can't perform the operation now. Try again later.
Articles 1–20